Xamic 500 Tablet

Tranexamic Acid is also employed in managing bleeding disorders like hemophilia and in certain cases of hereditary angioedema. The tablet is administered orally, with dosage tailored according to the severity of bleeding and clinical response. Xamic 500 is contraindicated in patients with active intravascular clotting, hypersensitivity to Tranexamic Acid, or history of thromboembolic disease.

Caution is advised in individuals with renal impairment, as dosage adjustment may be necessary. Common side effects are generally mild and may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Serious adverse events are rare but may involve thromboembolic complications. Xamic 500 should be used under medical supervision, with appropriate monitoring to ensure efficacy and safety.

It is essential to adhere to prescribed dosages and report any unusual symptoms promptly.